|
|
|
|
Virological Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir or Telaprevir in the U.S. (HCV-TARGET)
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
AM Di Bisceglie, A Kuo, VK Rustgi, MS Sulkowski,
TG Stewart, JM Fenkel, H ElGenaidi, M Mah'moud, GM Abraham, MW Fried, RK Sterling
for the HCV-TARGET Study Group
|
|
|
|
|
|
|